Informing investigators checklist
Investigators should be informed of trial closure via a letter.
The letter should:
- thank the investigator for their participation
- summarise patient status - number of withdrawals, deaths,
SUSARs, SAEs etc.
- remind the investigator of any continuing trial obligations
e.g. archiving
- availability for queries after trial closure
- arrange for the return of trial supplies and/or drug
supplies, if applicable
- advise of the possibility Eof audit or inspection if
applicable
- outline the results of the trial or provide a copy of the
trial report
- inform the investigators, if possible, of the expected
timing of the publication.
This has been contributed by Barbara Farrell who
prepared it for the third version of the Trial Management Guide.
Back to trial closure
This page was last updated September 2008.